SEC Form 4 · accession 0001888542-26-000007
Arteris, Inc. · AIP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Paul L Alpern
Officer — VP and General Counsel
Period of report
Jul 1, 2026
Accepted (ET)
Jul 2, 2026 · 4:07 pm EDT
Rule 10b5-1 plan
yes — trade under a plan
Issuer CIK
0001667011
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jul 1, 2026 | M | 4,000 | $0.56 | A | 84,384 | D | |
| Common Stock | Jul 1, 2026 | M | 2,500 | $9.28 | A | 86,884 | D | |
| Common StockF2 | Jul 1, 2026 | S | 2,096 | $44.0182 | D | 84,788 | D | |
| Common StockF3 | Jul 1, 2026 | S | 983 | $45.0793 | D | 83,805 | D | |
| Common StockF4 | Jul 1, 2026 | S | 2,521 | $46.2265 | D | 81,284 | D | |
| Common StockF5 | Jul 1, 2026 | S | 900 | $47.1131 | D | 80,384 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Incentive Stock Option (right to buy)F6 | $0.56 | Jul 1, 2026 | M | 4,000 | D | — | Oct 23, 2029 | Common Stock | 4,000 | 57,000 | D |
| Non-Qualified Stock Option (right to buy)F7 | $9.28 | Jul 1, 2026 | M | 2,500 | D | — | Feb 20, 2035 | Common Stock | 2,500 | 25,000 | D |
Explanation of responses
- F1Transaction made pursuant to a 10b5-1 trading plan that was adopted by the Reporting Person on February 23, 2026.
- F2The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $43.70 to $44.69 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F3The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $44.81 to $45.79 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F4The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $45.815 to $46.51 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F5The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $46.85 to $47.50 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F6Incentive stock option, 25% of the total shares vested on August 26, 2020; thereafter, 1/48th of the total shares vested monthly for 3 years, beginning on September 26, 2020.
- F7Non-qualified stock options, vesting in 16 equal quarterly installments of 1/16th each, beginning on April 1, 2025.